Zobrazeno 1 - 10
of 335
pro vyhledávání: '"J.F. Acar"'
Publikováno v:
Journal of Infection. 37:108-111
Objective: to determine the frequency of Clostridium difficile carriage in HIV-infected in- and out-patients, and to assess the role of this carriage in nosocomial transmission of C. difficile . Patients and methods: prospective study in a university
Publikováno v:
Research in Microbiology. 146:761-771
Of the 50 strains of β-lactamase-producing Branhamella catarrhalis isolated at Saint Joseph's Hospital (Paris) that were studied, 94% produced BRO-1 type β-lactamase and 6% produced the BRO-2 type. We examined the transfer of BRO-1 and BRO-2 genes
Publikováno v:
Réanimation Urgences. 1:604-612
Publikováno v:
Antimicrobial Agents and Chemotherapy. 35:519-523
Two associated resistance mechanisms were found in a nalidixic acid-susceptible (4 micrograms/ml) but fluoroquinolone-resistant (8 to 16 micrograms/ml) strain of Escherichia coli Q2 selected under norfloxacin therapy. As compared with the susceptible
Epidemiological study of Staphylococcus aureus resistance to new quinolones in a university hospital
Publikováno v:
Journal of Hospital Infection. 17:25-33
During a 14-month period, from December 1984 to February 1986, 630 Staphylococcus aureus isolates were identified at Broussais Hospital. Thirty-eight isolates (6%), from 35 patients, were found to be pefloxacin-resistant S. aureus (PRSA) with minimal
Autor:
J.F. Acar
Publikováno v:
Journal of chemotherapy (Florence, Italy). 11
Haemophilus influenzae is an important respiratory tract pathogen, and the prevalence of strains resistant to the antibiotics used to treat it has increased since the 1970s. Data on H. influenzae have been gathered in the Alexander Project, an ongoin
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 14:626-627
Autor:
J.F. Acar
Publikováno v:
Médecine et Maladies Infectieuses. 23:7
Publikováno v:
Médecine et Maladies Infectieuses. 13:104-110
Resume La rosaramicine est plus active que l'erythromycine sur les gonocoques, les pasteurelles, les colibacilles et la plupart des haemophilus. Elle est aussi active que la clindamycine sur Bacteroides fragilis, Clostridium perfringens, Flavobacteri
Publikováno v:
Médecine et Maladies Infectieuses. 10:156-162
Resume Le Cefotaxime est une nouvelle cephalosporine semi-synthetique, administrable par voie parenterale. Le pic serique moyen est voisin de 25 mcg/ml et la demi-vie de 90 minutes apres injection intramusculaire de 1 gramme. L'elimination urinaire d